Consistent with BPTES, tumor cells treated with V-9302 up-regulated the expression of PD-L1, Thus, there is the possibility of immune escape after treating tumor cells with V-9302, and the combined targeting of glutamine metabolism and PD-L1 showed a greater anti-tumor efficacy in mouse tumor models [71]. This evidence concerns the gene CD274 and neoplasm.